Patents Ending, Eli Lilly Chases New Drugs
Thursday, September 30, 2010 - 20:35
in Mathematics & Economics
The company is facing losing patent protection on drugs that accounted for 74 percent of its sales in 2009, a decline considered to be the worst patent cliff facing major companies in the industry.